SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-10-005034
Filing Date
2010-08-12
Accepted
2010-08-12 16:54:27
Documents
13
Period of Report
2010-07-04

Document Format Files

Seq Description Document Type Size
1 PFIZER INC. 10-Q a6393130.htm 10-Q 2644563
2 EXHIBIT 12 a6393130ex12.htm EX-12 94160
3 EXHIBIT 15 a6393130ex15.htm EX-15 10300
4 EXHIBIT 31.1 a6393130ex31-1.htm EX-31.1 16245
5 EXHIBIT 31.2 a6393130ex31-2.htm EX-31.2 16034
6 EXHIBIT 32.1 a6393130ex32-1.htm EX-32.1 4332
7 EXHIBIT 32.2 a6393130ex32-2.htm EX-32.2 4246
  Complete submission text file 0001157523-10-005034.txt   16629101

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pfe-20100704.xml EX-101.INS 2636331
9 XBRL TAXONOMY EXTENSION SCHEMA pfe-20100704.xsd EX-101.SCH 76071
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pfe-20100704_cal.xml EX-101.CAL 90119
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20100704_lab.xml EX-101.LAB 465210
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20100704_pre.xml EX-101.PRE 296677
13 XBRL TAXONOMY EXTENSION DEFINITION DOCUMENT pfe-20100704_def.xml EX-101.DEF 263082
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 101011713
SIC: 2834 Pharmaceutical Preparations